IWC
ARQT icon

Integrated Wealth Concepts’s Arcutis Biotherapeutics ARQT Stock Holding History

Integrated Wealth Concepts’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,216
Closed -$156K – 1747
2024
Q4 		$156K Sell
11,216
-554
-5% -$6.07K ﹤0.01% 1633
2024
Q3 		$109K Buy
11,770
+600
+5% +$5.92K ﹤0.01% 1606
2024
Q2 		$104K Buy
11,170
+50
+0.4% +$452 ﹤0.01% 1577
2024
Q1 		$110K Buy
11,120
+95
+0.9% +$709 ﹤0.01% 1576
2023
Q4 		$35.6K Buy
+11,025
New +$30K ﹤0.01% 1569

Other funds holding ARQT

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Integrated Wealth Concepts's ARQT Position: Q1 2025 in Review

Integrated Wealth Concepts sold out of Arcutis Biotherapeutics (ARQT) in Q1 2025, closing a stake of 11,216 shares — an estimated $156K sold.

Integrated Wealth Concepts first reported a position in ARQT in Q4 2023 and held it in 5 quarters. The position peaked at $156K in Q4 2024. 241 funds tracked by Wall St. Rank hold ARQT as of Q1 2025.

  • Integrated Wealth Concepts reported no remaining Arcutis Biotherapeutics position as of Q1 2025 after selling out during the quarter.
  • Integrated Wealth Concepts sold 11,216 Arcutis Biotherapeutics shares in Q1 2025, an estimated $156K.
  • Integrated Wealth Concepts first reported a position in Arcutis Biotherapeutics in Q4 2023 and held it in 5 quarters.
  • Integrated Wealth Concepts's Arcutis Biotherapeutics position peaked at $156K in Q4 2024.
  • 241 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q1 2025.

Based on Integrated Wealth Concepts's 13F filing for Q1 2025, filed 15 May 2025.